PHT-427 1191951-57-1
Product Description
.cp_wz table {border-top: 1px solid #ccc;border-left:1px solid #ccc; } .cp_wz table td{border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc;border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;}
Molecular Weight: 409.61 PHT-427 is a dual Akt and PDPK1 inhibitor (high affinity binding for the PH domains of Akt and PDPK1) with Ki of 2.7 μM and 5.2 μM, respectively.
PH-427 is a pleckstrin homology domain inhibitor to Akt/PDPK1. PH-427
significantly reduces phospho-Ser241-PDPK1 phospho-Thr308-Akt in PC-3
prostate cancer cells at 10 μM, which shows that PHT-427 could inhibit
both Akt and PDPK1. PHT-427 also inhibits translocation of the Akt and
PDPK1 PH domains in plasma membrane. PHT-427 induces
Apoptosis and inhibits AKT phosphorylation with IC50 of 8.6 μM (in
BxPC-3 cells), which mainly on its Ser473 residue and less strongly on
Thr308 residue without affecting total Akt protein expression. PHT-427
also shows antiproliferation in Panc-1 cells with IC50 of 65 μM.
PHT-427 shows great antitumor activity in BxPC-3 pancreatic, MCF-7
breast and A-549 NSCL cancer xenografts. PHT-427 gives up to an 80%
inhibition of tumor growth in BxPC-3 at doses of 125 to 250 mg/kg.
Cell Assay: [2]
Animal Study: [1]
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
Chemical Information
Molarity Calculator
Dilution Calculator
Molecular Weight Calculator
Contact us if you need more details on PHT-427 1191951-57-1. We are ready to answer your questions on packaging, logistics, certification or any other aspects about 1191951-57-1 PHT-427、1191951-57-1. If these products fail to match your need, please contact us and we would like to provide relevant information.
Molecular Weight: 409.61 PHT-427 is a dual Akt and PDPK1 inhibitor (high affinity binding for the PH domains of Akt and PDPK1) with Ki of 2.7 μM and 5.2 μM, respectively.
PH-427 is a pleckstrin homology domain inhibitor to Akt/PDPK1. PH-427
significantly reduces phospho-Ser241-PDPK1 phospho-Thr308-Akt in PC-3
prostate cancer cells at 10 μM, which shows that PHT-427 could inhibit
both Akt and PDPK1. PHT-427 also inhibits translocation of the Akt and
PDPK1 PH domains in plasma membrane. PHT-427 induces
Apoptosis and inhibits AKT phosphorylation with IC50 of 8.6 μM (in
BxPC-3 cells), which mainly on its Ser473 residue and less strongly on
Thr308 residue without affecting total Akt protein expression. PHT-427
also shows antiproliferation in Panc-1 cells with IC50 of 65 μM.
PHT-427 shows great antitumor activity in BxPC-3 pancreatic, MCF-7
breast and A-549 NSCL cancer xenografts. PHT-427 gives up to an 80%
inhibition of tumor growth in BxPC-3 at doses of 125 to 250 mg/kg.
Surface plasmon resonance (SPR) spectroscopy binding assays | All interaction analyses are performed with a Biacore 2000, Biacore 2000 Control Software v3.2, and BIAevaluation v4.1 analysis software. The PH domain GST-fusion Proteins (Akt1, IRS1, and PDK1) are immobilized on a CM5 Sensorchip using Biacore's Amine Coupling Kit to a level of 10,000 Response units (RUs). Small molecule analytes at concentrations ranging from 0.1 to 10 × the predicted KD are injected at a high flow rate (30μL/min). DMSO concentrations in all samples and running buffer are 1% (v/v) or less. |
---|
Cell Assay: [2]
Cell lines | Panc-1 cells |
---|---|
Concentrations | 1-50 μM |
Incubation Time | |
Method | Cell growth inhibition is determined using a micro-cytoxicity assay. Cells are plated in 96-well micro-cytoxicity at 5-10 × 103 cells per well (depending on cell doubling time) and grown for 7 days. PHT-427 dissolved in DMSO is added directly to the media, at various concentrations ranging from 1 to 50 μM. The endpoint is spectrophotometric determination of the protein content of each well using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. A concentration-response relationship at two or more concentration levels is used to obtain an IC50 for PHT-427. |
Animal Study: [1]
Animal Models | BxPC-3, Panc-1, MiaPaCa-2, PC-3, SKOV-3, A-549 or MCF-7 cells are injected subcutaneously into the flanks of female scid mice. | ||
---|---|---|---|
Formulation | 40 to 50 mg/mL in sesame seed oil | ||
Dosages | 125-250 mg/kg | ||
Administration | Oral administration | ||
Solubility | 5% DMSO/95% Corn oil, 5 mg/mL | ||
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species | Baboon | Dog | Monkey | Rabbit | Guinea pig | Rat | Hamster | Mouse |
Weight (kg) | 12 | 10 | 3 | 1.8 | 0.4 | 0.15 | 0.08 | 0.02 |
Body Surface Area (m2) | 0.6 | 0.5 | 0.24 | 0.15 | 0.05 | 0.025 | 0.02 | 0.007 |
Km factor | 20 | 20 | 12 | 12 | 8 | 6 | 5 | 3 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
Rat dose (mg/kg) = mouse dose (22.4 mg/kg) × | mouse Km(3) | = 11.2 mg/kg |
rat Km(6) |
Chemical Information
Molecular Weight (MW) | 409.61 |
---|---|
Formula | C20H31N3O2S2 |
CAS No. | 1191951-57-1 |
Storage | 3 years -20℃Powder |
---|---|
6 months-80℃in solvent (DMSO, water, etc.) | |
Synonyms | CS-0223 |
Solubility (25°C) * | In vitro | DMSO | 82 mg/mL (200.19 mM) |
---|---|---|---|
Water | <1 mg/mL ( | ||
Ethanol | 60 mg/mL (146.48 mM) | ||
In vivo | 5% DMSO/95% Corn oil | 5 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Chemical Name | 4-dodecyl-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide |
---|
Molarity Calculator
Dilution Calculator
Molecular Weight Calculator
Contact us if you need more details on PHT-427 1191951-57-1. We are ready to answer your questions on packaging, logistics, certification or any other aspects about 1191951-57-1 PHT-427、1191951-57-1. If these products fail to match your need, please contact us and we would like to provide relevant information.
Product Categories : PI3K/Akt/mTOR > Akt Inhibitor
Other Products
Hot Products
Astragaloside AChlortetracycline HCl 64-72-2Paclitaxel 33069-62-4Dexamethasone Acetate 1177-87-3Dinaciclib (SCH727965) 779353-01-4CHIR-124 405168-58-3Ro3280 1062243-51-9TAME 901-47-3CCG-1423 285986-88-110058-F4 403811-55-2Dabigatran (BIBR 953) 211914-51-1H 89 2HCl 130964-39-5T0901317 293754-55-9Aprepitant 170729-80-3Turofexorate Isopropyl (XL335) 629664-81-9BMS-378806 357263-13-9